A new paradigm of cardiohematological monitoring in patients with chronic myeloid leukemia taking tyrosine kinase inhibitors. (2022). Ukrainian Journal of Cardiology, 29(1-2), 72-86. https://doi.org/10.31928/1608-635X-2022.1-2.7286